Brain Tumor

Brain Tumor Articles

#ASCO2017 Cambridge Brain Mets Trial 1 (CamBMT1): A proof of principle study of afatinib penetration into cerebral metastases (mets) for patients (pts) undergoing neurosurgical resection, combined with low-dose, targeted radiotherapy (RT)—Phase 1b results.

Cambridge Brain Mets Trial 1 (CamBMT1): A proof of principle study of afatinib penetration into cerebral metastases (mets) for patients (pts) undergoing neurosurgical resection, combined with low-dose, targeted radiotherapy (RT)—Phase 1b results. Sub-category: Brain Metastases Category: Central Nervous System Tumors… Read More ›

#ASCO2017 Randomized, double-blind, phase III trial of a personalized peptide vaccination for human leukocyte antigen-A24-positive glioblastoma multiforme patients refractory to temozolomide-based therapy.

Randomized, double-blind, phase III trial of a personalized peptide vaccination for human leukocyte antigen-A24-positive glioblastoma multiforme patients refractory to temozolomide-based therapy. Sub-category: Central Nervous System Tumors Category: Central Nervous System Tumors Meeting: 2017 ASCO Annual Meeting Abstract No: 2000 Citation:… Read More ›

#ASCO2017 Association of aggressive resection with survival and progression-free survival in adult low-grade glioma: A systematic review and meta-analysis with numbers needed to treat.

Association of aggressive resection with survival and progression-free survival in adult low-grade glioma: A systematic review and meta-analysis with numbers needed to treat. Sub-category: Central Nervous System Tumors Category: Central Nervous System Tumors Meeting: 2017 ASCO Annual Meeting Abstract No:… Read More ›

ASCO 2017 on Twitter #ASCO2017

#ASCO2017 The Annual Meeting brings together more than 30,000 oncology professionals from around the world to discuss state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field. Twitter to follow: ASCO‏ Verified account @ASCO  Fabio Schutz‏ @FabioSchutz78 Oncopedia‏ @onco_pedia Ricardo Carvalho‏ @rcarvalhoonco Carolina K…. Read More ›